In the first half of 2026, 124 companies under the traditional APAC scope updated U.S. listing documents, producing 248 filing-update events in total. Among them, 31 companies made initial filings. At first glance, the pipeline still looks active. But active filing does not mean easy listing, and frequent updates do not necessarily mean a deal is close to pricing. [1]
Taken together, APAC companies pursuing U.S. IPOs in H1 2026 look less like a completed listing wave and more like a working queue. Companies are still revising documents, supplementing materials, and waiting for market windows. That is very different from having investor orders in hand and completing a public offering.
Filing updates in H1 2026 were lower than the same period in 2025, but still clearly above the H1 2024 level. That puts the market in a delicate position: activity did not continue accelerating after 2025, but it also did not fall back to the weaker 2024 level. From a quarterly perspective, Q1 contributed close to 60% of all H1 updates, with February as the peak month. April then fell sharply and became the quietest month of the first half.
The early-year concentration may reflect financial-statement validity periods, audit timetables, and filing-cycle management. But the lack of continued acceleration in Q2 suggests a more cautious rhythm. Companies are still preparing, but many may also be waiting for the right execution window.
For issuers, the time between the first filing and the latest update is often closer to the real time cost of the IPO process. Among H1 issuers for which the timeline can be calculated, the average company had already spent 8.2 months from initial filing to its latest update without listing. Twenty-six companies had stayed in the process for more than 12 months, while the median filing age was 5.5 months. [1]
The gap between the average and the median matters. The typical project is no longer a quick short-cycle listing, while a smaller group of long-running projects is pulling the overall cycle even longer. That makes the filing queue look active, but also shows that many issuers are still some distance away from actual pricing.
By sector, consumer, software, and services companies sit near the top of the queue. Hard technology and advanced manufacturing are not the main characters in this specific U.S.-bound pipeline. That structure is not surprising. U.S. equity investors still understand growth consumer businesses, software services, and asset-light business models, but they ask more detailed questions when companies are smaller and profitability is not yet stable.
These potential-growth issuers usually choose the U.S. market for its growth-investor base and expectation of more international liquidity. The problem is that investors may be willing to hear a growth story, but they are not willing to pay for every story. Revenue quality, customer concentration, repeat purchase behavior, gross margin, cost control, and post-listing liquidity will all be examined closely.
Industry Distribution of the U.S.-Bound Queue (108 Classified Companies)
|
Industry |
Relative scale |
Companies |
|
Consumer / Retail / Food |
21 |
|
|
Technology / Software / IT Services |
19 |
|
|
Business / Professional Services |
19 |
|
|
AI / Semiconductor / Advanced Manufacturing |
11 |
|
|
Other classified sectors |
38 |
Methodology: Industries were normalized for readability. Only the key categories discussed in the article are shown; other classified sectors include shell / SPAC / holding companies, healthcare, biotech, industrials, logistics, construction, financial services, energy, and environmental businesses. [1]
For consumer and services companies, brand strength, channel quality, and repeat purchases are more convincing than a simple overseas-growth narrative. For software and IT-services companies, customer retention, revenue visibility, and scalable delivery matter more than revenue growth alone. For business-services companies, order quality and cyclical exposure must be explained clearly. The U.S. market can provide access, but pricing power does not automatically belong to the issuer.
The core group in the U.S.-bound filing queue is still made up of small and mid-sized companies that need to prove their revenue model, customer base, and profit path.
If AI, semiconductor, and advanced-manufacturing companies are not especially prominent in the U.S.-bound queue, does that mean hard-tech financing has cooled? The broader data and current market tone suggest the opposite: large hard-tech projects have shifted their main stage. These companies need more than a listing venue. They need investors who can understand their supply-chain position, technology moat, and policy context.
Hong Kong provides a clearer signal on actual financing outcomes. HKEX reported that Hong Kong raised HK$110.4 billion from 40 IPOs in Q1 2026, far above the same period last year. [2] Reuters, citing LSEG data, reported that new listings in Hong Kong raised about US$22.45 billion in the first half of 2026, up nearly 57% year over year and marking the city’s strongest start to a year in five years. [3]
That creates a clear division of labor with the U.S.-bound queue. In the U.S. pipeline, many smaller companies are still waiting and updating filings. In Hong Kong and the A-share market, larger projects with heavier industrial narratives and greater financing needs are more likely to find a natural investor base. One market reflects preparation activity, while the other more directly reflects financing outcomes. They should not be placed on the same “market heat” chart without that distinction.
Cases such as Lingyi iTech and Luxshare Precision illustrate the point. Supply-chain leaders and advanced-manufacturing companies can often explain their industrial position and use of proceeds more naturally in Hong Kong. In the A-share pipeline, semiconductor and robotics companies also benefit from stronger domestic investor familiarity. For issuers, the question is not simply “where can we file?” It is “where are investors most likely to believe this capital should be deployed?” Reuters reported that Chinese technology companies raised HK$136.23 billion, or US$17.38 billion, through Hong Kong share listings in H1 2026, driven by AI, semiconductors, and advanced manufacturing. [4]
Different markets are not simply competing for the same issuers. The U.S. is acting more like a screening channel for small and mid-sized growth companies, while Hong Kong and A-share markets are becoming more natural financing venues for hard-tech and supply-chain leaders.
For Mainland China issuers, a U.S. listing is not reviewed only by the SEC. It also requires the CSRC filing process. Under the CSRC’s 2023 Trial Administrative Measures for overseas offerings and listings by domestic companies, a domestic company seeking an overseas offering and listing must submit a filing report and legal opinion within three working days after submitting its overseas listing application. If the filing materials are complete, the CSRC states that it will conclude the filing procedure within 20 working days; if the materials are incomplete, the issuer may be required to supplement them within 30 working days. [5]
The market’s general impression is that CSRC review for Chinese companies seeking U.S. IPOs was more demanding in H1 2026 than in the previous two years. The U.S.-bound filing queue continued to update, but there were not many highly visible Chinese companies that completed U.S. listings. DaSouChe, through DSC Holdings, became one of the most representative examples.
From the public supplementary-material process in H1 2026, many questions did not focus on the business model itself. They focused instead on underlying structural issues: ownership history, foreign-exchange procedures, low-price pre-listing share subscriptions, employee shareholding arrangements, full circulation of shares, and the identity of shareholders. In plain language, regulators wanted to know where the equity came from, whether anyone entered at a low price before listing, whether employee incentives were properly structured, who stood behind the shareholders, and whether the offshore structure and foreign-exchange procedures were complete.
DaSouChe’s case does not show that there were no regulatory issues. The CSRC filing notice for DSC Holdings confirmed that the filing materials had been submitted through its domestic operating entity and stated that the company planned to list on Nasdaq. It also required the company to implement rectification requirements from relevant authorities and report major matters after listing. [6] Reuters later reported that DSC Holdings, also known as DaSouChe, sought to raise up to US$62 million on Nasdaq after receiving rare approval from China’s securities regulator for a U.S. listing. [7]
The public result suggests that these issues did not prevent the company from moving forward. Many Mainland issuers are still supplementing materials, but the repeated questions appearing in public supplementary-material notices do not necessarily mean a project cannot list. They show that U.S. listings now require answers not only to U.S. market and SEC questions, but also to domestic regulatory questions about the issuer’s underlying structure.
For founders and management teams, the lesson is simple: companies need to decide earlier whether their old ownership, structure, capital, data, and business-boundary issues can withstand domestic regulatory review. If those issues can be explained clearly, the CSRC filing is part of the path. If they can only be explained at the last minute, the project can easily get stuck between supplementation and rectification.
Putting the data together, APAC companies seeking U.S. IPOs in H1 2026 can be summarized in one sentence:
Filing remains active, but listing remains difficult. Many companies are still waiting in line; far fewer have actually raised capital.
For issuers, market fit is becoming more important than the simple question of whether there is a listing window. Consumer, software, and services companies need to prove that their business models can survive U.S. investor scrutiny. Hard-tech and supply-chain leaders need to decide whether Hong Kong or A-share markets can better support their industrial narrative and financing scale. Mainland issuers choosing the U.S. path must manage SEC review and CSRC filing as one combined process, not two separate checklists.
[1] First Cover internal tracking dataset for traditional APAC companies updating U.S. IPO filing documents in H1 2026.
[2] HKEX, “Q1 2026 Hong Kong Market Update.” https://www.hkexgroup.com/Media-Centre/Insight/Insight/2026/HKEX-Insight/Q1-2026-Hong-Kong-Market-Update?sc_lang=en
[3] Reuters, “Chinese tech companies seek nearly $6 billion in Hong Kong listing rush,” June 29, 2026. https://www.reuters.com/world/asia-pacific/chinas-luxshare-precision-industry-seeks-raise-up-31-billion-hk-share-sale-2026-06-29/
[4] Reuters, “Chinese tech firms, from Apple suppliers to OpenAI rivals, raise $17 billion in Hong Kong,” July 9, 2026. https://www.reuters.com/world/asia-pacific/chinese-tech-firms-apple-suppliers-openai-rivals-raise-17-billion-hong-kong-2026-07-09/
[5] CSRC, Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, 2023. https://www.csrc.gov.cn/csrc_en/c102030/c7125865/7125865/files/CSRC%20Announcement%20% 5B2023%5D%20No.%2043%EF%BC%9ATrial%20Administrative%20Measures%20of%20Overseas %20Securities%20Offering%20and%20Listing%20by%20Domestic%20Companies.pdf
[6] CSRC, Filing notice for DSC Holdings Ltd., April 24, 2026. https://www.csrc.gov.cn/csrc/c105984/c7628436/content.shtml
[7] Reuters, “China’s DSC Holdings seeks up to $62 million in Nasdaq share sale,” June 18, 2026. https://www.reuters.com/world/asia-pacific/chinas-dsc-holdings-seeks-up-62-million-nasdaq-share-sale-2026-06-18/
Disclaimer: This article is for informational and research purposes only and does not constitute any investment advice.
Form 10-S Arrives, But Quarterly Disclosure Won't Disappear
U.S. IPO Trends, SPAC Activity, and Listing Regulatory Rules